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A clinical trial of intestinal transplantation was initiated at the University of 
Pittsburgh In May of 1990. A total of 34 patients received either a combined 
liver/small bowel graft (n=20). an isolated small.bowel graft (n=10). or a 
multivisceral graft (n=4). Induction as well as maintenance immunosuppression 
was with FK506 and steroids. Sixteen patients were male and 18 were female. 
with ages ranging between 4 months and 50 years. There were 7 deaths. which 
were attributed to gratt-versus-host disease (n-1) post transplant 
Iymphoproliferative disease (n=1). and sepsis (n=5). Transplantation of the 
intestine has evolved into a feasible operation with satisfactory results. Overall 
patient survival of 79%. and overall graft survival of 7:3% has been achieved. 
These survivors are free of TPN; the majority are home. Though this endeavour 
has reqUired significant human and economic resources. the encouraging 
results justify further clinical trials. 
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Prior to the imroduction of total parenleral Ilutritlon (TPN). thc 
prognosis of pOll1el1ls with illlestlllOlI failurc (short gut syndrome I 
WolS depcndent upon m.!Olptalion of Ihe n:malllil1]! howei . The usc 
of TPN hOls IInproved the long-term outcomc. (Mrk - ~EFfk .'l year 
survival) and 1\ Ihe accepted therapeul1c modality. Complic:ltions 
from this ther'lpy. howcver. arc frequcnt. Liver failurc secondary 
In TPN. ,l1ld venous acccss complications (infcction ,Ind 
Ihromhosis I arc thc most incapacital1ng. The carc of thcse paticnts 
IS perhaps onc lIt the most difficult challengcs In the field of 
I ransplal1lal1ol1 IOd'IY. 
Transplantation of the small howcl was first reportcd 
c.'pcrtl11enwlly as an isolated organ gr;lft hy Ltllehel in 1(}5(} '. 
One ycar later Starzl included the small howel as part of a 
lflultlvl~lDcral graft in dogs '. The cllllical ;Ipplicability of small 
howei transplantation did not. howcvcr. enjoy thc rapid expansion 
c\pcnenccd hy livcr and kidney transplantallon durlllg thc same 
perilld ;Ihcr the illlroduction Ill' cyciosporlll A. This was anrihuted 
to a IlIgh IIIcidence Ill' graft loss lrom rejecllon. IIIfections. and 
t~dlllical complicatIOns '. 
Wc rcport here the e\perience accumulated wllh tntcslInal 
transplantallol1 11\ K~~ palle",s transplanted at thc UniversllY of 
Pillshurgh between May 191)() to January 191)J. Highlighls olthc 
cvaluatllJn process. donor and reCIpient operallon. and pl~f­
"pcrallve l'are Will he reViewed. 
PRE-TRANSPLANT CONSIDERATIONS 
The Illdicallons lor IIltestlOal transplamallon at the cmverslIY 01 
Pillsburgh arc listed in TABLE I. Hepallc IIlICgrlly Is assessed by 
,Iandard livcr transplant protocols looklOg lorlaundlcc. degree of 
"nthcllc d\slunclIon and the presence 01 ponal hypenenslOn. or 
Ihe g~ pat;ents reported in this senes. O~ presented wllh liver 
Jvsfuncllon as eVidenced by total bilirubm levels r:m~mg between 
2:3 and 50 mg/dl and signs of ponal hypcnenslon. The seventy of 
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Necrotizing Enterocolitis 
Gastroschisis 
Volvulus 
Pseudo-obstruction 
Hirschsprung's Disease 
Intestinal Atresia 
Microvillus Inclusion Diseasc 
Malrotation 
Crohn's Disease 
Thrombolytic Disorder 
Trauma 
Radiation Enteritis 
Desmoid Tumor 
Familial Polyposis 
fA BI.I! I. 1 ndicalitm, IlIr ,fmall inlt!slinailran.fpianlalicm. 
fihrotic changes 011 liver hiopsy has also hccn helpful when 
associated with hepatosplcnomegaly, ascites. and esophagcal 
vanecs. Thcse palle11lS arc candidatcs lor replacement of thc liver 
and transpl:lIltallon olthe small howcl. 
Due to the availability of altcmallvc thcrapy (TPN). candidates 
~clccted for isolated transplantation of the small bowel have been 
I imitcd to those patients with intcstinal failurc who are totally 
dependent on TPN for thcir survival. but. however are presenting 
l'llmplications of this therapy. Evidencc of persistent liver 
function test abnormalities (no synthctic dysfunction). a history of 
multiple septic episodes from catheter infection. and progressive 
thrombosis of access sites should all he considered. 
The prescnt sophistication of multivisceral organ harvesting 
and graft acceptancc can provide for thc transplantation of organs 
,uch as the liver. stomach. duodenum. small howel. pancreas. and 
colon. The gralt composlle Will vary according to the anatomic 
and funcllonal inlcgrlly of thc reclpient's remaining 
gastrointeslllla! tract. and thc presencc of abnormalities in other 
organs. 
THE OPERATION 
The donor IS always 01 the same ABO blood group as the reCipient 
and is usually 01 similar or smaller Sile. There IS no functional 
assessment 01 the IIltesllne pnor to donallon: a history of normal 
tntesllnal funclIon In a reterral for potenllal liver donation IS 
,uUicient. Highlights of the technIque and donor preparalion an: 
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Intestinal Decontamination 
(Donor and Recipient) 
eThan 5 Years 5·12 Years 
Amphotericin 8 100 mg 250 mg 
Tobramycin 10 mg 40 mg 
Polymycin E 25 mg 50 mg 
Systemic Antibiotics· 
Celotaxlme· 25 mglkg/dose Q 8 hrs IV 
AmpIcillin 25 mg/kgldose Q 6 hrs IV 
>12 Years 
500 mg 
80 mg 
100 Mg 
'II the reCIpient has had recent bacterIal or fungal InfectIons these 
InfectiouS agents should b'! coverea In Ihe prophylactIc regimen 
FIGURE I. Tht mullivisctral harvtst should allow jluibi/ity not onl.v for the 
abdominal proctdurt but also for tht thoracic o~an procurement. Stparau 
infusion of preservallon fluid (instil allows for compltte blanch;n/( of the 
liver Kraft. !B.v permiSJion of SURGERY. G.vnrcoloKY &: Obslrtrics. Stanl TE 
tI 01. 'J. 
as outlined in FIGURE I. and the reader is relerred to the 
hibliography for a more detailed deSCription .. '. 
The early stages of the recipient operation focus on the status 
of the native liver. and the preservation of the remalOing bowel. 
The tinal decision as to the needs of the patient as far as organs are 
concerned. is made at this time. If the liver IS to be excised it can 
he accomplished with removal of the retrohepallc vena cava (as 
for a standard orthotopic liver transplanll or in a "piggy back" 
fashion t preserving the retrohepatlc vena cava) ". A portacaval 
,hunt IS performed for decompression of the remaining splanchnic 
organs t stomach. duodenum. pancreas. spleen 1''', This is not 
reqUired in recIpients of a complete muhivisceral or isolated small 
howel grafl. 
Vascular Intlow to the muhivisceral or liver small bowel gratt 
uses a "carrel patch" containing the coeliac and superIor 
mesenterIC arterIes. whIch IS anastomosed to the recIpient 
tnfrarenal aorta t with or without an interposition graft of donor 
thoraCIC or abdominal aonal. The venous dramage of the gralt IS 
into the hepallc vl!ms of the recIpient or by replacement of the 
retrohepauc vena cava. The ponacaval shunt can be taken down 
and a rectpient portal vein to donor portal vein anastomoSIS 
perlormed. In Ihe Isolated small bowel gralt the superior 
mesentenc anery IS anastomosed directly to the mfrarenal aona. 
The venous drainage of the Isolated small bowel gralt can be Into 
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the nattve superior mesenteric vem. the portal vein at the level 01 
the hepatic hilus. or inferior vena cava'. ' 
The graft is reperfused allowing bleeding to occur from the 
superior mesenteric vein (isolated small bowel I!rafll or from the 
infrahepatlc vena cava (liver/small bowel or m~ltivisceral I!raftl. 
This allows for drainage of the potassium rich preserv-alton 
solution. The gastrointe~tlnal tract IS reconstructed with a 
proximal and distal anastomosis to Ihe nativ.e intestine in a 
standard fashion. A proximal tube Jelunostomv and a I!astrostomv 
is performed to drain the proXImal howel. Biliarv re~onstructio~ 
is reqUired only in recipients of a liver/small bowel graft. and is 
performed to the most proximal end of the transplanted jejunum 
(FIGURE 2). 
IMMUNOSUPPRESSION 
One gram of intravenous hydrocortisone (children) or 
methylprednisolone (adults) is given immediately after graft 
reperfusion. FK506* (0.15 • 0.2 mg/kg/dayl is then begun by 
continuous intravenous infusion. targeting levels at between 2 and 
3 ng/ml. Oral FK506 is initiated once intestinal motility is 
present. A steroid tapcr of methylprednisolone is staned at a dose 
of 100 mg (children) or 2(X) mg (adults) and reduced over a period 
of 5 days to 10 mg (children) or 20 mg (adults) per day. 
Prostoglandin E, (Prostin) is administered at 0.003 to 0.009 
IJ/kg/min intraoperatively and then continued for 5 days. This is 
given for the beneficial effect on FK506 nephrotoxicity 
Azathioprine is used to supplement baseline immunosuppression 
in cases of recurrent rejection or FK506 nephrotoxicity. 
Although induction therapy requires multiple drugs. the long 
term management entails reduction of FKS06 and stopping steroid 
therapy if the pallent is clinically well. ~ost paediatric patients 
can be managed by monotherapy with FK506. 
* FK506 is a novel new immunosuppressant which has similar 
actions to cyclosporin A and is currently undergoing extensive 
evaluation, 
POST·OPERATIVE CARE 
Recipients of a com hi ned liver/small howel graft or a complete 
multivisceral graft arc commonly in liver tallure. therefore the care 
with respect to pulmonary lunctlon. In!l=ctlOn surveillance. and 
liver graft funcllon is similar 10 a routine post liver transplant 
recipient. The intenSive care unit stav and total hospital stay 
however. arc significantly longer. Early on there is a signilicant 
capillary leak. with "Ihird spacing" of tluid into the interstitial 
tissues. Renal funcllon may he impaired due to the extensive 
surgery. hlood transfUSIon requirements. intraoperauve 
Sm ... Bowe. fran.p.antatlon SUI,.r, 
I' 
FIGURE 2. qh~ thrre basic OptrtllJOII' ptrj"D"II~d 011 t •• J-I rrci,wll" Itrrr 
r~"D"DKti 
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RC\:lplcnts 01 livcr/~rnall howcl gralh havc u,ually rC4ulrcd a 
mcan 01 flO day, to hc\:ome indcpcndcnt 01 TP:\. \\ hcrca~ I,olatcd 
,mall huwcl grail rccipicnt, havc hc!;omc IIldcpcndcnt 01 TPN at 
approxlmatcly .W day, pmt-Iran'planl. WClght and hcight 
ffhrCIf~C hClwccn tran'planl and latc'i lollow up havc hccn 
con"'tcntly good In thc childrcn. howcvcr 'OI11C adults havc lost 
\\clght altcr Iran,plantallun t FIGURE -+1. Thi, ha, hccn duc to a 
Ic"cr adaplahility to oral inlakc in ,omc 11111iIlvi'cl:ral rCl·lplcnt~K 
and al,o to thc prc'cn\:c (If mild to modcratc Elhcslf~ prc-transplant 
in othcr, 
COMPLICATIONS 
(;raft dysfunction 
Rarely. intcstinal allogl".1h rcjc\:tion may he asymptomatic. More 
wmmunly a wmbinatiun of fcver. abdominal pain and distension. 
nau!\ea and vomiting. and a sudden inncase in stomal output 
occurs. Thc 'lOrna m:ly bc\:ome ocdematous. pale or 
erythcmatous. and friahlc, dastrollltc~tinal hlecding can he seen 
wilh passagc of dark hurgundy to tarry ,tools in l'ascs of severe 
rCIection In which Ihere arc ul\:erations and or ,'oughing or the 
1I11cstlllai l11u\:o,a, Translocation ul hactcna ihrnugh thc InJured 
c:plthcliulIl f~ \:ommon and \:an occur wnh h,lclcna and rungl. 
I II tcs\llW I dccontamlnatiun must hc Instituted during ihesc 
c:plsodcs ", 
Endl)scopically the transplanted IIltcsllnal mUl'usa losc~ its line 
velvety ,Ippearance and may initially hecomc i~y:haemlc or dusky. 
wllh focal ulccrations. Severe rcjcctlon will prescnt With 
increased crythcma. Iriahility. with a granular mucosal pattcrn and 
diffu~c ulccrations. Loss or peristalsis i, common. 
Histologil·.t1ly Ihcrc is ocdema 01 thc lamina propria with 
11101l01lucic:lr cell infiltrates (small and/or hla~tll: Iymphocytcsi. 
villous hiuntlllg and cryptitis, ~curotrophi"K ell'lIlophlis. and 
macrophage' may hc ,een travcrsing thc muscularis mucosa ''', 
Thc degrcc 01 eplthclial cell necrosis varics with the ,cvcruy of 
rC.lectIl1l1. COl11plctc lllucos,11 ,Ind uvpt dc,trucllon arc ,ecn in 
pallcnts with severc rCJection. Thc mu\:o,al surfacc IS repla\:ed hy 
',!ranulallon tlsSliC and II1flammatory pscudomemhrancs. 
ChrOniC rCleClion has heen seen 111 2 pallents aller scvcrc ,Icute 
releClion. Clinically thcre IS chronl\: weIght Ilh\ \\ Ith Intcrrnttlellt 
diarrhoea. lever. ;1110 hlecding. If iSlOlo!,!lcaliv t herc IS v Ii lous 
hiulltillg. local ulcerations. and epllhelialmctaplasla .. 
The Illcldcnl'c of acute IIltestinal allogralt reJecllon has been 
rcponcd 10 he KWic in Ihe isolated small bowel rcclpients. and 77("" 
In the liver/small bowcl reCipients: the Inctdcl1\:c 01 acute livcr 
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allograft rejection in the liver/small bowel reclpicnts was 55/ff", 
Graft rejection may he treated initially with bolus stcroid 
therapy (intravenous hydrocortisone or methvlprednisolonel in 
cascs or mild reJcction. and wilh a ,temld taper in Cases of 
moderate to sevcre reJccllon. The FK50fl lrough levels should he 
optimised by either thc oral or Intravenous routes.' The use of 
OKT3** is the ncxt line 01 therapy when rejection has progrcssed 
llll a stcroid taper. Howevcr. this should he considered earlier if 
Ihere is evidencc or impending mucosal exfoliation. or there is 
significant FK50fl ncphro or neurotoxicity. 
** OKT3 is a murinc monoclonal antibody directed against 
human T \:clls. It is uscd for induction of immunosuppression and 
treatment of severe rejection. 
Post-operative haemorrhage 
t- ~ -~~t¥f;y:I~ !fl''!.:!\'.';'';i'\. ,"! 
Intra-abdominal bleeding is a common complication since most . 
patients have had many previous abdominal procedures' which 
leave extensive raw peritoneal surfaces. If the recipient also has 
significant liver disease the coagulopathy and ponal hypenension 
may make intraoperative bleeding difficult to control. The 
temporary ponacaval shunt is a significant aid in the pert'onnance 
of haemostasis. Immediatc postoperative hleedlll!,! is usually from 
a vas\:ular anastomosis. abdomtnal wound. or retroperitoneal 
surfaces. 
Biliary complications 
Biliary Icaks can occur only in recipients (llthc liver/small bowel 
graft. One such complication occurred in a paediatric recipient 
who presented Icakage of hili:lry fluid Ihrough the abdominal 
wound. in a setting of candida pcritonitis. The 
choledocolcJunmtOlllY was revised u'ln!,! a U-tube through the 
I ivcr. howevcr. the pallcnt succumhcd to II1lel.:lIOn -+ weeks later. 
Vascular complications 
Thrombosis 01 the hepallc artcry has heen ,een in a paediatric 
reCIpient of a liver small howe I gralt. The pallent developed acutc 
hepatiC gangrene and re4ulred retransplantatlon of the hepallc 
~DompEFnent of the !,!ralt. The superior IIlcsenteric anery and the 
inlestmal component 01 the graft did not suffcr thrombosis. The 
patient died of influcnza B pncumol1la 3 weeks later. 
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FIGURE 48. P,rr,,.n/, .."i/l'" Cltlill/l" illu,,1U Itllllff 1ItUIId. Ii,," lit", is 
II Iti/llt" illcid'lIc, of Oliff,..,';'''' 011 TPN. 14110. ",,,ltin,c,,. rrrifl nft,u ... 
t .... ,.,. '",II" It",.,.,,.,. """,, ,.,,,i",,,;,,;,,,. .. ·,.;"It" 
nGVR,.; J. Radiograph ofi""sti"al allograft after .f,v,n ,xfoliGtiv, t.VfH 
rrj,ctio" shuwi"g a "tubulis,d" PO""" and strictuns. 
haemodynamic instability. and drug toxicities. Only one patient 
has required a kidney transplant postoperatively. 
Ventilatory suppon is usually more prolonged in these patients. 
Muscle wasting and malnutrition. panial or complete paralysis of 
the right hemidiaphragm_ and occasional discrepancies in 
Jonor/recipient size producing an rncreased intra-abdominal 
volume with compre.;sion of the thoracic cavity. are responsible 
factors. Four patients have required tracheostomies because of the 
need for prolonged ventilatory suppon. 
Any history of recent nosocomial infections just prior to 
transplant should be addressed wilh appropriate specific 
anllbiotics. otherwise broad spectrum intravenous antibiotic 
prophylaxis is acceptable and is given for a period of 5 days post-
operatively. Intestinal decontamInation in the recipient as 
illustrated in FIGURE I is perfonned for a period of (, weeks. and 
Juring episodes of rejection. 
Nutrtlional support is by standard TPN solutions which are 
tapered gradually as oral or enteral fcedings (via gastric or jcjunal 
tubel arc advanced. Tube feedings .Ire initiated using Peptamen. 
which i, an isotonic dipeptide formula containing medium chain 
trlglycerides and glutamine. This is later convened to Completc B 
which IS a lactose gluten free diet contarning dietary fibres to 
promotc normalisation of intesltnal mOlllity and function. Most 
pallellls do nO! voluntarrly cat adequate amounts carlyon. This 
has been panlcularly scvere to paediatriC n:clpicnts. 
Assessment 01 small bowel funcllon has heen through the usc 
01 absorpllon studies of D-xylose. FK506. and the quantitation of 
fat in the stool. Most patients present satisfactory absorption 
curves for D-xylose within the first postoperativc month. with 
absorpllon improving over time. Abnormal results should always 
prompt an aggressIve search for rejection. The mailllenance of 
,atlsfactory FK506 blood trough Icvcls off intravenous therapy IS 
uscd as the indtcator 01 adequate absorption. This has occurred at 
a mean of 28 days post-transplant. and has tcnded to he longer In 
recIpIents of a muhivisceral graft. TIle el\;cretion of fat in the stool 
has bcen abnonnal in almost all patients. however. there have been 
llO c1inrcal Implications to this phenomenon. 
RadiologIC evaluations hy standard barium gastrointestinal 
,crrcs arc valuable In assessing mucosal pallcrn and mOlllit\,. 
Intesllnal grail rejection. when mild. can he suspected when there IS 
cVldence of mucosal oedema. Severe reJecllon. with el\;loiiation of 
the mucosa. WIll ablate the nonnal mucosal pattern and can be seen 
as segments of '"tubulised'" intestine and stnctures ,FIGURE 3). 
\10nitonng for tntesttnal grail rejection focuses on clinical 
.:valuallons and gross morphology of Ihe intestine at the level of 
the stoma and at endoscopy. The stomal output IS assessed for 
,olume. consIstency. and the presence of redUCing substances. 
or malabsorption. The presence of blood in the stool is always an 
ominous sign. and must be assumed to be rejection until proven 
otherwise. Endoscopic evaluations are perfonned routinely twice 
a week through the transplanl ileostomy. Upper endoscopics are 
perfonned when indicated. 
RESULTS 
Thiny-four patienls received intestinal transplams between May 
1990 to January 1993. There were 16 male and I H female 
patiems. with ages ranging between 6 months to 50 years. Twenty 
patienls had combined liver/small bowel transplants. 10 patients 
had isolated small bowel transplants and 4 patients had 
multivisceraltransplants. The follow up time has ranged between 
5 mOnlhs and 3 years' (TABLE 2l. 
INTF.STlNAL (iRAn RECIPIENTS ~ f j ~ . ,.!J H. 
MAY 199ft-JANUARY 199J 
.. .... ' .. ~ .. , . 
AGE SliRVIVAL 
. ~; ;: ~-j , /it:":}F! • 
YEARS SEX .DJA(iNffiIS ··(jRArr DAYS lIN 
3.2 F Nee SBIL >YM Free 
·U M Gastroschisis SBIL >1143 Free 
2.M M Inteslinal alresia SBIL .'115 DiedJPTLD 
0.6 F Intestinal alresia SBIL 23 DiedlGVHD 
1.1 F Volvulus SBIL >5K4 Free 
1.7 F Volvulus SBIL > 5K2 Free 
2.5 F Microvillus Inclusion SB :> 502 Free 
1.3 M Inteslmal atresia SB >447 Free 
10.2 F m~eudoobstruct ion SB > .'75 Free 
1.5 M NEe SBIL 70 Died/Sepsis 
4.2 F GastRlSChlSis SBIL > 279 Free 
1.4 M Gastroschisis SBIL 29 Died/Sepsis 
O.K M MicRlvlllus Indusiun SBIL > 23K Free 
U.S M Gastroschisis SBIL > 232 Free 
4.() F Pseudouhstrucl ion MV > 1~4 Free 
J.6 M NEe SBIL '17 DicdlSepsis 
0.9 F Gastroschisis SBIL > 92 Free 
55 M Volvulus SBIL > 71 Free 
3t M Gunshot wound SB 776 DicdlSep"s· 
~S F SMA Ihrnmtxlsls SBIL > '156 Free 
21 \1 Traflie acclde:nt SBIL > 57J ranial 
.'2 M CA & SMA thrombosIs MV > 519 Panial 
50 F Crohn's disease SB >444 Free 
34 F Desmoid lumor SB >407 Toeal--
3K M Crohn's disease: SB .'76 Dicd/Sepsls 
" F Crohn's disease: SB > .'69 Free 
25 M Crohn"s dlsea.'iC SBIL > .\53 Free 
2'1 F o.:smOid tumor SBIL > OD1~ Free 
24 \I CA & SMA Ihrombosls MV > 292 Free 
20 F Traflic aCCident SB > 2112 Free 
'2 F CA & SMA Ihrombosls ,\1 V > 217 Free 
1'1 \I Trallic aCCident SBIL > 214 Free 
44 r- SMA thromboSIS SBIL > 1'10 Free 
.17 F Familial polypoSIS SB > 109 Free 
• Relr:msplamallon al 22 monlhs •• Graft removed at II months. 
SB Small txlwel onl ... 
SBIL Small boweilliver 
MV Mullivlsceral 
P1l.D pEF~t·tr:m~plant Iymphoprohferallve disease 
GVHD· Graft·versu5-hosl disease tposslble. 
which can be seen In the event of rejection. baclenal overgrowth. T "BLE 2. Dtuo Oil til' J4 illt.uuw ,,., rrapUltU 
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Gastrointestinal complications 
The mo~t common Intestinal complication after small bowel 
transplantation is leakage through either the proximal or distal 
~astrEllntestlnal anastomosis. Also. there have heen leaks from 
native duodenal and coloOic ~tumpsK a~ .,.,ell as gastrostomy 'iiles. 
SurgICal reVIsion of these leaks and aggressive Ireatment of 
perlloneal soilage with frequent laparotomIes and approprlale 
~lnllhiEltic therapy have heen performed. 
Gastrolntesllnal motility disordcrs have occurrcd in bOlh nallve 
and transplantcd Intestine. GaslrtC alony with pylorospasm has 
heen common and ~clr limiting. Hypermolilily of the allograft 
IIltestlne IS Irequenlly found early after transplantation. and can be 
~ontrolh::d with agents such as paregoric. loperamide. immodium. 
pectin. or somatostatin. Sudden increases or decrcases in transit 
lime should initiate a search for rejection. 
Gastrointcstinal blceding has occurred almost e~clusively with 
rcjection of thc allograft intestine. Management strategy must 
focus on endoscopic evaluation and treatment of the rejection 
episode. 
Infections 
Infections remain thc most significant cause of morbidity and 
mortality after intcstinal transplantation. PredispOSing factors 
Include Ihe ~everity of liver failure. as well as the presence of 
intra-abdominal. pulmonary. or line sepsis prior to transplant. 
Technically more cifficult transplant procedures with increased 
operative time. incrcased blood transfusions. and increased 
likelihood of re-explorations arc signihcant risk factors. 
Inlections have included bacterial. fungal and viml organisms. 
These Illay manifest as pnmary pulmon:try. peritoncal. or venous 
catheter infecllons. or be part of a translocation phcnomenon in a 
~raft damaged hy rejection. All deaths after intestinal 
transplantatlllll have had severc related infe~tiEFnsK One recipient 
of two isolated intestinal grafts died of infectiow, complications 
after rctransplantatlon. One child died following a biliary leak and 
,<:psis: two ,hildren suflered disruplIon of the proximal intestinal 
anastomosIS and s.:psis. One of these dlildre:l also suffered 
hepatIC artery thromhm,ls wllh fullntnant hepallc gangrene 
(re4ulrtllg a new liver !,!raltJ and eventually died of Inlluenza B 
pneumOllla: the other ,hlld presented a hasehne lI11munodcliciency 
dlsurdcr and devdoped p//('UfI/(lcr.lfls 11/,.,,,1/ pneumonia and 
prohahlc !!ralt versus host disease. 
The I1Imt frequent hacterial pathogens have heen staphylOCOCCI 
and .:nterococci. Viral agents that have hcen signilicant Include 
adenOVIrus. ~ytomegalovirusK parainlluenza. influcnza B. and 
RSV. Post-transplant Iymphoproliferallve di~ease associated with 
the bp~tell1-Barr vIrus has occurred in J rhildren. and resulted m 
"lie latahty. Thcse patients presented with multifllcal disease and 
\\we trc:lted WIth IIllravenous acyclOVIr or ganclclovir. as well as 
wlthholdillg 01 IInmunosuppression. Rejectloll 01 the IIltestinal 
~llfo!!ralt may occur during the recovery phase and should be 
Ir.:ated \\ Ith ,t.:rolds and rClOslltutllln "f FK500 
ImmUIl!lSUppre\\lOll. Paticnts who have died 01 complications 
rdated to Ireatment 01 intestinal allograll relectlon Include the 
10110\\ Ill!!: I reCIpient of an isolatcd small howel died of infection 
,Iller retransplantatlon lor chronIC rejection. Another Isolated 
,mall howe I recIpIent died of candida sepsIs alter salvage for a 
,evere e\loliatlve type Intestinal allogr:llt relection. One 
paediatriC reCIpient 01 a liver/small bowel grail severely rejected 
the IIltestme and reqUIred OKT3. He then went on to develop 
,.:\ere adenOVIrus hepatllis and subse4uently developed liver 
laduTe!. nle intestinal port ton 01 the allo~ralt recovered. however. 
Ihe seventy 01 liver injury from the adenOVIrus mfectlon required 
a combined liver/small bowel retr.msplantation. Severe rcjection 
of the intestinal allograft ensued and the child did not respond to 
OKT3. He died of enterococcal sepsis and intestinal bleeding. 
CONCLUSION 
Success with intestinal transplantation has required lechnical and 
dinical managemcnt modifications. The most imponant factor. 
however. remains the maintenance of adequate 
immunosuppression with FK506. Most complications or 
managemcnt difficulties will hinge around maintaining an intact. 
normally functioning allograft intestinc: all other concerns remain 
secondary. 
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